Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis

Hepatology

Volumn 14, Issue 3, 1991, Pages 426-431

  Adams, David H ^a   Hubscher, Stefan G ^b   Shaw, Jean ^a   Johnson, Gerald D ^b   Babbs, Christopher ^c   Rothlein, Robert ^d   Neuberger, James M ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ARTICLE; BILE DUCT INJURY; CLINICAL ARTICLE; HUMAN; IMMUNE SYSTEM; LIVER CIRRHOSIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; STAINING;

BILE DUCTS; CELL ADHESION MOLECULES; CHOLANGITIS, SCLEROSING; HUMAN; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LIVER; LIVER CIRRHOSIS, BILIARY; STAINING AND LABELING; SUPPORT, NON-U.S. GOV'T;

EID: 0026042723     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840140305     Document Type: Article

References (31)

1. Comparison of the clinicopathological features of primary sclerosing cholangitis and primary biliary cirrhosis
2. Primary biliary cirrhosis: chronic non‐suppurative destructive cholangitis
3. Primary biliary cirrhosis: diagnosis and pathogenesis
4. Primary biliary cirrhosis: a model autoimmune disease
5. Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis
6. Serum autoantibodies, ulcerative cholitis and primary sclerosing cholangitis
7. An autoantibody profile in primary sclerosing cholangitis
8. Lymphocyte populations in liver biopsy specimens from patients with primary biliary cirrhosis
9. Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epilthelia in primary biliary cirrhosis
10. Hepatic beta‐2‐microglobulin distribution in primary biliary cirrhosis
11. Aberrant expression of HLA DR molecules on bile duct epithelium in primary biliary cirrhosis
12. Expression of MHC products by normal and abnormal bile duct epithelium
13. Enhanced autoreactivity of T‐lymphocytes in primary sclerosing cholangitis
14. PBC is a dry gland syndrome with features of chronic graft‐versus host disease
15. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts
16. Mechanism of specific tumour cell lysis by alloimmune T‐lymphocytes: resolution and characterization of discrete steps in the cellular interaction
17. Leucocyte adhesion to cells in immune and inflammatory responses
18. Lymphocyte function–associated antigen 1 (LFA‐1): a surface antigen distinct from lyt‐2.3 that participates in T lymphocytemediated killing
19. Leucocyte‐endothelial interactions
20. The lymphocyte function–associated LFA‐1, CD‐2 and LFA‐3 molecules: cell adhesion receptors of the immune system
21. The requirement for lymphocyte function–associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester
22. Purified intercellular adhesion molecule‐1 (ICAM‐1) is a ligand for lymphocyte functionassociated antigen‐1 (LFA‐1)
23. Functional cloning of ICAM‐2: a cell adhesion ligand for LFA‐1 homologous to ICAM‐1
24. Induction of IL1 and interferon, tissue distribution, biochemistry and function of a natural adherence molecule (ICAM‐1)
25. Induction of intercellular adhesion molecule‐1 on primary and continuous cell lines by pro‐inflammatory cytokines
26. Intercellular adhesion molecule 1 on liver allografts during rejection
27. Alkaline phosphatase‐fast red, a new flourescent label
28. Expression of blood group–related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases
29. Immunohistochemical study of adhesion molecules in liver inflammation
30. Locally administered monoclonal antibodies to lymphocyte function–associated antigen‐1 and to L3T4 prevent cutaneous graftversus‐host disease
31. Functional consequences of anti‐ICAM‐1 in cynomolgus monkeys with renal allografts